Galectin-7 (Gal-7), like Gal-1 and Gal-3, seems to have tumor-promoting effects: in a Gal-7 deficient mouse model, a delayed development of HER2+ breast cancer was observed. Here, LGALS1 is linked to breast carcinoma.